Assembly Biosciences, Inc. Variable Lease, Cost
Assembly Biosciences, Inc. (ASMB) reported Variable Lease, Cost of $817.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-19
- Assembly Biosciences, Inc. variable lease, cost for the quarter ending 2021-12-31 was $254.00K, a 30.79% decline year-over-year.
- Assembly Biosciences, Inc. variable lease, cost for the quarter ending 2021-09-30 was $312.00K, a 23.72% decline year-over-year.
- Assembly Biosciences, Inc. variable lease, cost for the quarter ending 2021-06-30 was $408.00K, a 0.00% change year-over-year.
- Assembly Biosciences, Inc. variable lease, cost for the quarter ending 2021-03-31 was $343.00K, a 20.77% increase year-over-year.
- Assembly Biosciences, Inc. variable lease, cost for fiscal 2025 was $817.00K, a 12.38% increase from fiscal 2024.
- Assembly Biosciences, Inc. variable lease, cost for fiscal 2024 was $727.00K, a 51.66% decline from fiscal 2023.
- Assembly Biosciences, Inc. variable lease, cost for fiscal 2023 was $1.50M, a 4.39% decline from fiscal 2022.
- Assembly Biosciences, Inc. variable lease, cost for fiscal 2022 was $1.57M, a 19.44% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $817.00K 10-K · filed 2026-03-19 | |||
| 2024-12-31 | $727.00K 10-K · filed 2026-03-19 | |||
| 2023-12-31 | $1.50M 10-K · filed 2025-03-20 | |||
| 2022-12-31 | $1.57M 10-K · filed 2024-03-28 | |||
| 2021-12-31 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $566.00K derived: sum of 2 quarters · filed 2023-03-22 | $974.00K derived: sum of 3 quarters · filed 2023-03-22 | $1.32M 10-K · filed 2023-03-22 |
| 2021-09-30 | $312.00K 10-Q · filed 2021-11-04 | $720.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.06M 10-Q · filed 2021-11-04 | $1.43M derived: sum of 4 quarters · filed 2022-03-11 |
| 2021-06-30 | $408.00K 10-Q · filed 2021-08-05 | $751.00K 10-Q · filed 2021-08-05 | $1.12M derived: sum of 3 quarters · filed 2022-03-11 | $1.53M derived: sum of 4 quarters · filed 2022-03-11 |
| 2021-03-31 | $343.00K 10-Q · filed 2021-05-06 | $710.00K derived: sum of 2 quarters · filed 2022-03-11 | $1.12M derived: sum of 3 quarters · filed 2022-03-11 | $1.53M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-12-31 | $367.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $776.00K derived: sum of 2 quarters · filed 2022-03-11 | $1.18M derived: sum of 3 quarters · filed 2022-03-11 | $1.47M 10-K · filed 2022-03-11 |
| 2020-09-30 | $409.00K 10-Q · filed 2021-11-04 | $817.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.10M 10-Q · filed 2021-11-04 | $1.39M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $408.00K 10-Q · filed 2021-08-05 | $692.00K 10-Q · filed 2021-08-05 | $985.00K derived: sum of 3 quarters · filed 2021-08-05 | $1.29M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $284.00K 10-Q · filed 2021-05-06 | $577.00K derived: sum of 2 quarters · filed 2021-05-06 | $878.00K derived: sum of 3 quarters · filed 2021-05-06 | $1.18M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $594.00K derived: sum of 2 quarters · filed 2021-02-25 | $894.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.19M 10-K · filed 2021-02-25 |
| 2019-09-30 | $301.00K 10-Q · filed 2020-11-05 | $601.00K derived: sum of 2 quarters · filed 2020-11-05 | $900.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $300.00K 10-Q · filed 2020-08-05 | $599.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $299.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |